Is 6 months of androgen suppression therapy plus radiotherapy of benefit in patients with localized prostate cancer?

Alan Pollack; Eric M. Horwitz

doi:10.1038/ncponc0056

Is 6 months of androgen suppression therapy plus radiotherapy of benefit in patients with localized prostate cancer?

Fox Chase Cancer Center

Research output: Contribution to journal › Short survey › peer-review

Original language	English
Pages (from-to)	12-13
Number of pages	2
Journal	Nature Clinical Practice Oncology
Volume	2
Issue number	1
DOIs	https://doi.org/10.1038/ncponc0056
State	Published - Jan 2005

Keywords

Adenocarcinoma/drug therapy
Aged
Antineoplastic Agents, Hormonal/administration & dosage
Combined Modality Therapy
Drug Administration Schedule
Goserelin/administration & dosage
Humans
Injections, Intramuscular
Injections, Subcutaneous
Leuprolide/administration & dosage
Male
Prospective Studies
Prostatic Neoplasms/drug therapy
Radiotherapy, Conformal
Treatment Outcome

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/ncponc0056

Cite this

@article{995bdc34487348678375bd6f674a91de,

title = "Is 6 months of androgen suppression therapy plus radiotherapy of benefit in patients with localized prostate cancer?",

keywords = "Adenocarcinoma/drug therapy, Aged, Antineoplastic Agents, Hormonal/administration & dosage, Combined Modality Therapy, Drug Administration Schedule, Goserelin/administration & dosage, Humans, Injections, Intramuscular, Injections, Subcutaneous, Leuprolide/administration & dosage, Male, Prospective Studies, Prostatic Neoplasms/drug therapy, Radiotherapy, Conformal, Treatment Outcome",

author = "Alan Pollack and Horwitz, {Eric M.}",

year = "2005",

month = jan,

doi = "10.1038/ncponc0056",

language = "English",

volume = "2",

pages = "12--13",

journal = "Nature Clinical Practice Oncology",

issn = "1743-4254",